Seroepidemiology of hepatitis A and B in the general population in Hong Kong: protocol of a cross-sectional survey using spatial sampling in a highly urbanised city

Chin Man Poon, Denise P Chan, Shui Shan Lee, Ngai Sze Wong, Chin Man Poon, Denise P Chan, Shui Shan Lee, Ngai Sze Wong

Abstract

Introduction: Differences in immunisation policies have significantly reshaped the epidemiology of hepatitis A and B in the population. Assessment of the susceptibility and transmission potential of these two types of vaccine-preventable hepatitis would enhance the capacity of public health authorities for viral hepatitis elimination. Focusing on Hong Kong, the objectives of this study comprise the determination of the population-level seroprevalence of hepatitis A and B and an examination of the risk factors for virus transmission and the population impacts of vaccinations.

Methods and analysis: This is a cross-sectional household survey on hepatitis A and B. By using socially homogeneous building groups as sampling frame, eligible members of 1327 spatially selected households would be invited to complete a questionnaire and provide blood samples for serological testing (anti-hepatitis A virus, hepatitis B surface antigen, hepatitis B surface and core antibody). The main measures comprise a set of metrics on the prevalence of hepatitis A and B. Analysis would be conducted to examine the association of risk factors with the tested markers and describe the attitudes towards viral hepatitis vaccination.

Ethics and dissemination: Ethical approval from the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee, and approval for laboratory safety from the Chinese University of Hong Kong have been obtained. The study results will be presented in scientific forums to update on the epidemiology of hepatitis A and B and inform the development of new vaccination strategies in Hong Kong.

Trial registration number: NCT04371276.

Keywords: epidemiology; hepatology; immunology; public health.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Study flow diagram.
Figure 2
Figure 2
Distribution of building groups.

References

    1. World Health Organization . Global hepatitis report, 2017. Available: [Accessed 4 May 2020].
    1. World Health Organization . Regional office for the Western Pacific. Regional action plan for viral hepatitis in the Western Pacific 2016-2020: a priority action plan for awareness, surveillance, prevention and treatment of viral hepatitis in the Western Pacific Region. Available: [Accessed 4 May 2020].
    1. Centre for Health Protection, Department of Health . Surveillance of viral hepatitis in Hong Kong – 2018 report. Available: [Accessed on 22 Apr 2020].
    1. Liu KSH, Seto WK, Lau EHY, et al. . A territorywide prevalence study on blood-borne and enteric viral hepatitis in Hong Kong. J Infect Dis 2019;219:1924–33. 10.1093/infdis/jiz038
    1. Poon C. Update on hepatitis A in Hong Kong. Communicable Diseases Watch 2015;12:65–7.
    1. Ho B, Wong B, Chan K. Summary on the recent upsurge of hepatitis A infection among MSM in Hong Kong. Communicable Diseases Watch 2017;14:96–7.
    1. Scientific Committee on Vaccine Preventable Diseases, Centre for Health Protection, Department of Health, Hong Kong . Hepatitis A immunization in high risk groups and outbreak situations, 2006. Available: [Accessed 4 May 2020].
    1. Wong KH, Liu YM, Ng PS, et al. . Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong. J Med Virol 2004;72:538–44. 10.1002/jmv.20040
    1. Suen SS, Lao TT, Chan OK, et al. . Relationship between age and prevalence of hepatitis B infection in first-year university students in Hong Kong. Infection 2013;41:529–35. 10.1007/s15010-012-0379-6
    1. Lao TT, Sahota DS, Suen SS, et al. . Impact of neonatal hepatitis B vaccination programme on age-specific prevalence of hepatitis B infection in teenage mothers in Hong Kong. Epidemiol Infect 2013;141:2131–9. 10.1017/S0950268812002701
    1. Lao TT, Sahota DS, Law LW, et al. . Age-specific prevalence of hepatitis B virus infection in young pregnant women, Hong Kong special administrative region of China. Bull World Health Organ 2014;92:782–9. 10.2471/BLT.13.133413
    1. Lin AW, Wong KH. Surveillance and response of hepatitis B virus in Hong Kong special administrative region, 1988-2014. Western Pac Surveill Response J 2016;7:24–8. 10.5365/wpsar.2015.6.3.003
    1. Cui F, Shen L, Li L, et al. . Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis 2017;23:765–72. 10.3201/eid2305.161477
    1. World Health Organization . Global health sector strategy on viral hepatitis 2016-2021. Available: [Accessed 5 May 2020].
    1. Centre for Health Protection, Department of Health . Seroprevalence rates of hepatitis A virus antibodies. Available: [Accessed 20 May 2020].
    1. Lemeshow S, Hosmer DW, Klar J. Lwanga SK: would health organisation. adequacy of sample size in health studies. Chichester: Wiley, 1990.
    1. SHK L, Seto WK, Wong DK. A population-based study on the seroprevalence of viral hepatitis in Hong Kong, China. Hepatol Int 2016;10:S207–8.
    1. United Nations . Designing household survey samples: practical guidelines. New York: United Nations Publication, 2008.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit